agilon health, inc. (NYSE:AGL) Receives $9.10 Average Price Target from Analysts

Shares of agilon health, inc. (NYSE:AGL) have been assigned a consensus recommendation of “Hold” from the nineteen brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $9.10.

AGL has been the topic of several recent research reports. Stifel Nicolaus decreased their price target on agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a report on Wednesday, May 1st. Baird R W upgraded agilon health to a “hold” rating in a report on Thursday, May 30th. Truist Financial raised their target price on agilon health from $6.40 to $6.50 and gave the stock a “hold” rating in a report on Friday, May 24th. Citigroup started coverage on agilon health in a report on Monday, April 22nd. They set a “neutral” rating and a $6.00 target price on the stock. Finally, Robert W. Baird started coverage on agilon health in a report on Thursday, May 30th. They set a “neutral” rating and a $6.00 target price on the stock.

Institutional Investors Weigh In On agilon health

Several institutional investors have recently bought and sold shares of the company. Capital World Investors lifted its stake in agilon health by 7.4% in the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after acquiring an additional 3,813,214 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock worth $533,501,000 after purchasing an additional 1,191,253 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares in the last quarter. Capital International Investors raised its stake in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock worth $127,256,000 after purchasing an additional 3,195,087 shares in the last quarter.

agilon health Price Performance

Shares of AGL stock opened at $6.34 on Friday. The stock’s fifty day moving average is $6.54 and its 200-day moving average is $6.02. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.33 and a current ratio of 1.33. The stock has a market capitalization of $2.61 billion, a PE ratio of -9.06 and a beta of 0.60. agilon health has a 52 week low of $4.41 and a 52 week high of $21.52.

agilon health (NYSE:AGL) last announced its earnings results on Tuesday, May 7th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.03. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.62 billion. agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. Equities research analysts expect that agilon health will post -0.34 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.